Rapid Community Engagement in Response to SARS-CoV-2 Funding Opportunities: New York City, 2020‒2021.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 36446061.
- Also identified by DOI 10.2105/AJPH.2022.307072 and PMC identifier 9707719.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In response to fast-turnaround funding opportunities, collaborations have been forming across the country to address severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disparities. Here we describe the process, notes from the field, and evaluation results from a new collaboration involving multiple partners, formed in October 2020 in New York City as part of the Rapid Acceleration of Diagnostics initiative. We used the validated Research Engagement Survey Tool to evaluate the partnership. Results can inform future research and improve engagement efforts aimed at reducing SARS-CoV-2 disparities. (<i>Am J Public Health</i>. 2022;112(S9):S904-S908. https://doi.org/10.2105/AJPH.2022.307072).
Medical subject headings
- COVID-19